ResMed | RMD - Current Liabilities

Stock Price
254.74
Daily Change
-3.57 -1.38%
Monthly
3.82%
Yearly
5.90%
Q1 Forecast
250.35

ResMed reported $1.25B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Ansell USD 522M 98.6M Jun/2025
AtriCure USD 77.84M 9M Sep/2025
Baxter International USD 3.78B 836M Sep/2025
Cochlear AUD 602.3M 23.8M Jun/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
CSL USD 4.82B 1.26B Jun/2025
Dexcom USD 3.34B 27.3M Sep/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Fisher Paykel Healthcare NZD 471.3M 29.1M Dec/2025
Globus Medical USD 465.96M 41.29M Sep/2025
Haemonetics USD 548.32M 16.91M Sep/2025
Hologic USD 951.3M 25.9M Dec/2025
Idexx Laboratories USD 1.25B 27.93M Sep/2025
Insulet USD 647.7M 362.4M Sep/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
Masimo USD 369.7M 222.4M Sep/2025
Medtronic USD 11.53B 1.35B Jun/2025
Philips EUR 7.03B 171M Sep/2025
Ramsay Health Care AUD 4.47B 750.4M Jun/2025
ResMed USD 1.25B 7.39M Dec/2025
Sigma Healthcare AUD 1.7B 1.33B Dec/2025
Sonic Healthcare AUD 2.23B 92.84M Dec/2024
Steris USD 888.9M 37.7M Sep/2025
Teleflex USD 773.03M 56.88M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025